Prima BioMed to Present at 2nd Annual Cancer Immunotherapy Conference – EIN News (press release)
|
Prima BioMed to Present at 2nd Annual Cancer Immunotherapy Conference
EIN News (press release) /EINPresswire.com/ — SYDNEY, AUSTRALIA–(Marketwired – Jan 22, 2017) – Prima BioMed Ltd ( ASX : PRR ) ( NASDAQ : PBMD ) ("Prima" or the "Company") announces that the submission titled "TACTI-mel, Two ACTive Immunotherapies in Melanoma: … |
